Global Live Cell Imaging Market Growth (Status and Outlook) 2022-2028

Global Live Cell Imaging Market Growth (Status and Outlook) 2022-2028

As the global economy mends, the 2021 growth of Live Cell Imaging will have significant change from previous year. According to our (LP Information) latest study, the global Live Cell Imaging market size is USD million in 2022 from USD 1553.3 million in 2021, with a change of % between 2021 and 2022. The global Live Cell Imaging market size will reach USD 2554.4 million in 2028, growing at a CAGR of 7.4% over the analysis period.
The United States Live Cell Imaging market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Live Cell Imaging market, reaching US$ million by the year 2028. As for the Europe Live Cell Imaging landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Live Cell Imaging players cover Carl Zeiss (Germany), Leica Microsystems (Germany), Olympus (Japan), and GE Healthcare (U.K.), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Cell Imaging market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Equipment
Consumables
Software
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Pharmaceutical Companies
Biotechnological Companies
Diagnostic Laboratories
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Carl Zeiss (Germany)
Leica Microsystems (Germany)
Olympus (Japan)
GE Healthcare (U.K.)
BD (U.S.)
Thermo Fisher Scientific (U.S.)
Danaher (U.S.)
Sigma-Aldrich (U.S.)
Nikon (Japan)
Molecular Devices (U.S.)
PerkinElmer (U.S.)
BioTek Instruments (U.S.)

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Live Cell Imaging Market Size 2017-2028
2.1.2 Live Cell Imaging Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Live Cell Imaging Segment by Type
2.2.1 Equipment
2.2.2 Consumables
2.2.3 Software
2.3 Live Cell Imaging Market Size by Type
2.3.1 Live Cell Imaging Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Live Cell Imaging Market Size Market Share by Type (2017-2022)
2.4 Live Cell Imaging Segment by Application
2.4.1 Hospitals
2.4.2 Pharmaceutical Companies
2.4.3 Biotechnological Companies
2.4.4 Diagnostic Laboratories
2.4.5 Others
2.5 Live Cell Imaging Market Size by Application
2.5.1 Live Cell Imaging Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Live Cell Imaging Market Size Market Share by Application (2017-2022)
3 Live Cell Imaging Market Size by Player
3.1 Live Cell Imaging Market Size Market Share by Players
3.1.1 Global Live Cell Imaging Revenue by Players (2020-2022)
3.1.2 Global Live Cell Imaging Revenue Market Share by Players (2020-2022)
3.2 Global Live Cell Imaging Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Live Cell Imaging by Regions
4.1 Live Cell Imaging Market Size by Regions (2017-2022)
4.2 Americas Live Cell Imaging Market Size Growth (2017-2022)
4.3 APAC Live Cell Imaging Market Size Growth (2017-2022)
4.4 Europe Live Cell Imaging Market Size Growth (2017-2022)
4.5 Middle East & Africa Live Cell Imaging Market Size Growth (2017-2022)
5 Americas
5.1 Americas Live Cell Imaging Market Size by Country (2017-2022)
5.2 Americas Live Cell Imaging Market Size by Type (2017-2022)
5.3 Americas Live Cell Imaging Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Cell Imaging Market Size by Region (2017-2022)
6.2 APAC Live Cell Imaging Market Size by Type (2017-2022)
6.3 APAC Live Cell Imaging Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Live Cell Imaging by Country (2017-2022)
7.2 Europe Live Cell Imaging Market Size by Type (2017-2022)
7.3 Europe Live Cell Imaging Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Live Cell Imaging by Region (2017-2022)
8.2 Middle East & Africa Live Cell Imaging Market Size by Type (2017-2022)
8.3 Middle East & Africa Live Cell Imaging Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Live Cell Imaging Market Forecast
10.1 Global Live Cell Imaging Forecast by Regions (2023-2028)
10.1.1 Global Live Cell Imaging Forecast by Regions (2023-2028)
10.1.2 Americas Live Cell Imaging Forecast
10.1.3 APAC Live Cell Imaging Forecast
10.1.4 Europe Live Cell Imaging Forecast
10.1.5 Middle East & Africa Live Cell Imaging Forecast
10.2 Americas Live Cell Imaging Forecast by Country (2023-2028)
10.2.1 United States Live Cell Imaging Market Forecast
10.2.2 Canada Live Cell Imaging Market Forecast
10.2.3 Mexico Live Cell Imaging Market Forecast
10.2.4 Brazil Live Cell Imaging Market Forecast
10.3 APAC Live Cell Imaging Forecast by Region (2023-2028)
10.3.1 China Live Cell Imaging Market Forecast
10.3.2 Japan Live Cell Imaging Market Forecast
10.3.3 Korea Live Cell Imaging Market Forecast
10.3.4 Southeast Asia Live Cell Imaging Market Forecast
10.3.5 India Live Cell Imaging Market Forecast
10.3.6 Australia Live Cell Imaging Market Forecast
10.4 Europe Live Cell Imaging Forecast by Country (2023-2028)
10.4.1 Germany Live Cell Imaging Market Forecast
10.4.2 France Live Cell Imaging Market Forecast
10.4.3 UK Live Cell Imaging Market Forecast
10.4.4 Italy Live Cell Imaging Market Forecast
10.4.5 Russia Live Cell Imaging Market Forecast
10.5 Middle East & Africa Live Cell Imaging Forecast by Region (2023-2028)
10.5.1 Egypt Live Cell Imaging Market Forecast
10.5.2 South Africa Live Cell Imaging Market Forecast
10.5.3 Israel Live Cell Imaging Market Forecast
10.5.4 Turkey Live Cell Imaging Market Forecast
10.5.5 GCC Countries Live Cell Imaging Market Forecast
10.6 Global Live Cell Imaging Forecast by Type (2023-2028)
10.7 Global Live Cell Imaging Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Carl Zeiss (Germany)
11.1.1 Carl Zeiss (Germany) Company Information
11.1.2 Carl Zeiss (Germany) Live Cell Imaging Product Offered
11.1.3 Carl Zeiss (Germany) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Carl Zeiss (Germany) Main Business Overview
11.1.5 Carl Zeiss (Germany) Latest Developments
11.2 Leica Microsystems (Germany)
11.2.1 Leica Microsystems (Germany) Company Information
11.2.2 Leica Microsystems (Germany) Live Cell Imaging Product Offered
11.2.3 Leica Microsystems (Germany) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Leica Microsystems (Germany) Main Business Overview
11.2.5 Leica Microsystems (Germany) Latest Developments
11.3 Olympus (Japan)
11.3.1 Olympus (Japan) Company Information
11.3.2 Olympus (Japan) Live Cell Imaging Product Offered
11.3.3 Olympus (Japan) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Olympus (Japan) Main Business Overview
11.3.5 Olympus (Japan) Latest Developments
11.4 GE Healthcare (U.K.)
11.4.1 GE Healthcare (U.K.) Company Information
11.4.2 GE Healthcare (U.K.) Live Cell Imaging Product Offered
11.4.3 GE Healthcare (U.K.) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 GE Healthcare (U.K.) Main Business Overview
11.4.5 GE Healthcare (U.K.) Latest Developments
11.5 BD (U.S.)
11.5.1 BD (U.S.) Company Information
11.5.2 BD (U.S.) Live Cell Imaging Product Offered
11.5.3 BD (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 BD (U.S.) Main Business Overview
11.5.5 BD (U.S.) Latest Developments
11.6 Thermo Fisher Scientific (U.S.)
11.6.1 Thermo Fisher Scientific (U.S.) Company Information
11.6.2 Thermo Fisher Scientific (U.S.) Live Cell Imaging Product Offered
11.6.3 Thermo Fisher Scientific (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Thermo Fisher Scientific (U.S.) Main Business Overview
11.6.5 Thermo Fisher Scientific (U.S.) Latest Developments
11.7 Danaher (U.S.)
11.7.1 Danaher (U.S.) Company Information
11.7.2 Danaher (U.S.) Live Cell Imaging Product Offered
11.7.3 Danaher (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Danaher (U.S.) Main Business Overview
11.7.5 Danaher (U.S.) Latest Developments
11.8 Sigma-Aldrich (U.S.)
11.8.1 Sigma-Aldrich (U.S.) Company Information
11.8.2 Sigma-Aldrich (U.S.) Live Cell Imaging Product Offered
11.8.3 Sigma-Aldrich (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Sigma-Aldrich (U.S.) Main Business Overview
11.8.5 Sigma-Aldrich (U.S.) Latest Developments
11.9 Nikon (Japan)
11.9.1 Nikon (Japan) Company Information
11.9.2 Nikon (Japan) Live Cell Imaging Product Offered
11.9.3 Nikon (Japan) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Nikon (Japan) Main Business Overview
11.9.5 Nikon (Japan) Latest Developments
11.10 Molecular Devices (U.S.)
11.10.1 Molecular Devices (U.S.) Company Information
11.10.2 Molecular Devices (U.S.) Live Cell Imaging Product Offered
11.10.3 Molecular Devices (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Molecular Devices (U.S.) Main Business Overview
11.10.5 Molecular Devices (U.S.) Latest Developments
11.11 PerkinElmer (U.S.)
11.11.1 PerkinElmer (U.S.) Company Information
11.11.2 PerkinElmer (U.S.) Live Cell Imaging Product Offered
11.11.3 PerkinElmer (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 PerkinElmer (U.S.) Main Business Overview
11.11.5 PerkinElmer (U.S.) Latest Developments
11.12 BioTek Instruments (U.S.)
11.12.1 BioTek Instruments (U.S.) Company Information
11.12.2 BioTek Instruments (U.S.) Live Cell Imaging Product Offered
11.12.3 BioTek Instruments (U.S.) Live Cell Imaging Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 BioTek Instruments (U.S.) Main Business Overview
11.12.5 BioTek Instruments (U.S.) Latest Developments
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings